Cargando…

Novel Lentivirus-Based Method for Rapid Selection of Inhibitory Nanobody against PRRSV

The emergence and re-emergence of porcine reproductive and respiratory syndrome virus (PRRSV) has resulted in huge economic losses for the swine industry. Current vaccines are of limited efficacy against endemic circulating PRRSV variants. New strategies against PRRSV infection are in urgent need. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ze-Hui, Lei, Kai-Xia, Han, Guang-Wei, Xu, Hui-Ling, He, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077216/ https://www.ncbi.nlm.nih.gov/pubmed/32092857 http://dx.doi.org/10.3390/v12020229

Ejemplares similares

TAT Nanobody Exerts Antiviral Effect against PRRSV In Vitro by Targeting Viral Nucleocapsid Protein
por: Ren, Jiahui, et al.
Publicado: (2023)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

Construction of an alpaca immune antibody library for the selection of nanobodies against Drosophila melanogaster proteins
por: Qiu, Jianxiang, et al.
Publicado: (2023)

Immunization against Small Ruminant Lentiviruses
por: Reina, Ramsés, et al.
Publicado: (2013)

Vectored vaccines to protect against PRRSV
por: Cruz, Jazmina L.G., et al.
Publicado: (2010)

Yeast surface display platform for rapid discovery of conformationally selective nanobodies
por: McMahon, Conor, et al.
Publicado: (2018)

Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015)

Development and Characterization of a Nanobody against Human T-Cell Immunoglobulin and Mucin-3
por: Xia, Mingyuan, et al.
Publicado: (2022)

Nanobody-based immunosensing methods for safeguarding public health
por: Zhang, Jiarong, et al.
Publicado: (2021)

Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins
por: Van Fossen, Elise M., et al.
Publicado: (2022)

Adherens Junction Formation Inhibits Lentivirus Entry and Gene Transfer
por: Padmashali, Roshan, et al.
Publicado: (2013)

Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein
por: Li, Tiansen, et al.
Publicado: (2017)

Comparative evaluation of 4 commercial modified‐live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV‐1 and PRRSV‐2 challenge
por: Oh, Taehwan, et al.
Publicado: (2020)

Ginsenoside Rg1 Suppresses Type 2 PRRSV Infection via NF-κB Signaling Pathway In Vitro, and Provides Partial Protection against HP-PRRSV in Piglet
por: Yu, Zhi-qing, et al.
Publicado: (2019)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
por: Serrano-Rivero, Yunier, et al.
Publicado: (2023)

Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation
por: Han, Kiwon, et al.
Publicado: (2014)

Selection of Specific Nanobodies against Lupine Allergen Lup an 1 for Immunoassay Development
por: Hu, Yaozhong, et al.
Publicado: (2021)

Inhaled nanobodies against COVID-19
por: Martinez-Delgado, Gustavo
Publicado: (2020)

Rapid and sensitive detection of PRRSV by a reverse transcription-loop-mediated isothermal amplification assay
por: Zhang, Lei, et al.
Publicado: (2011)

Preparation of Specific Nanobodies and Their Application in the Rapid Detection of Nodularin-R in Water Samples
por: Yang, Jinyi, et al.
Publicado: (2021)

Positive selection of HIV host factors and the evolution of lentivirus genes
por: Bożek, Katarzyna, et al.
Publicado: (2010)

PRRSV Vaccine Strain-Induced Secretion of Extracellular ISG15 Stimulates Porcine Alveolar Macrophage Antiviral Response against PRRSV
por: Liu, Hongbin, et al.
Publicado: (2020)

RNA packaging in lentiviruses
por: Lever, Andrew ML
Publicado: (2009)

Expanding Possibilities for Intervention against Small Ruminant Lentiviruses through Genetic Marker-Assisted Selective Breeding
por: White, Stephen N., et al.
Publicado: (2013)

Effects of lentivirus-mediated endostatin on endothelial progenitor cells
por: Ai, Jing, et al.
Publicado: (2017)

Protection provided by a commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) 1 vaccine (PRRSV1-MLV) against a Japanese PRRSV2 field strain
por: Miranda, Joel, et al.
Publicado: (2023)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

The structural biology of PRRSV
por: Dokland, Terje
Publicado: (2010)

Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022)

Improved Vaccine against PRRSV: Current Progress and Future Perspective
por: Nan, Yuchen, et al.
Publicado: (2017)

Cellular Innate Immunity against PRRSV and Swine Influenza Viruses
por: Crisci, Elisa, et al.
Publicado: (2019)

Antiviral Strategies of Chinese Herbal Medicine Against PRRSV Infection
por: Bello-Onaghise, God’spower, et al.
Publicado: (2020)

Glycyrrhiza polysaccharides inhibits PRRSV replication
por: Yang, Youbing, et al.
Publicado: (2023)

Escherichia coli surface display for the selection of nanobodies
por: Salema, Valencio, et al.
Publicado: (2017)

An optimized method for high-titer lentivirus preparations without ultracentrifugation
por: Jiang, Wei, et al.
Publicado: (2015)

Characterization of Two Immunodominant Antigenic Peptides in NSP2 of PRRSV-2 and Generation of a Marker PRRSV Strain Based on the Peptides
por: Li, Dong-Yan, et al.
Publicado: (2022)

Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV
por: Chen, Xin-xin, et al.
Publicado: (2021)

Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
por: Xia, Lijie, et al.
Publicado: (2020)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Lentivirus Gene Engineering Protocols
por: Takeuchi, Y
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_iivde8t7qm4k6qrfb77uq3o169